American Academy of Family Physicians

Printer-friendly version

Share this on AAFP Connection

Share this page

AAFP Recruiting Practices for Smoking Cessation Pilot

'Office Champions' Program Aims to Ramp Up Anti-Tobacco Activities

By News Staff

The AAFP is recruiting 50 family medicine practices for a pilot project that will train "office champions" to implement system changes that encourage the integration of tobacco cessation activities in daily office routines.
Stock photo of generic pack of cigarettes
The program will educate these office champions through an online training module, live teleconferences and a practice manual. The office champions will be required to submit an implementation plan to the AAFP and track and report results.

"I can say from experience that changing the system in which you practice can help improve care on a consistent basis," said Saria Carter Saccocio, M.D., of Rome, Ga., a member of the Academy's Tobacco Cessation Advisory Committee.

Carter Saccocio, who is associate director of the Floyd Family Medicine Residency in Rome, said that implementing a similar tobacco cessation program improved her residency's quality of care by putting a bigger emphasis on the issue.

New Tobacco Provisions Take Effect

It has been one year since President Obama signed the Family Smoking Prevention and Tobacco Control Act, which gives the FDA authority to regulate tobacco products. During that time, the FDA has achieved numerous milestones included in the act, such as establishing the agency's Center for Tobacco Products and implementing new statutory authorities that increase scrutiny of tobacco product manufacturers.

The following provisions of the act took effect June 22:

  • FDA rules that limit the sale, distribution, and marketing of cigarettes and smokeless tobacco to protect the health of children and adolescents become legally enforceable;
  • advertising or labeling of tobacco products with the descriptors "light," "mild" or "low-tar" or similar descriptors is prohibited without an FDA order; and
  • larger health warning labels for smokeless tobacco products are required to rotate on labels and advertising and be displayed on packaging.
The AAFP marked the June 22 anniversary by joining the American Academy of Pediatrics, the American College of Physicians, the American Congress
of Obstetricians and Gynecologists, and the AMA in voicing support for the regulations.

In a joint statement, the organizations urged the FDA to vigorously enforce regulations designed to reduce use of tobacco products by children and adolescents.

"The FDA's authority to regulate tobacco products represents an unprecedented opportunity to protect the American public, especially children, from the harm caused by these dangerous products," said AAFP President Lori Heim, M.D., of Vass, N.C., in the statement. "An effective strategy against tobacco use requires approaches that prevent people from using it in the first place and measures to assist in quitting.

"The FDA's new role in preventing the marketing and illegal sale of tobacco products to minors will bolster family physicians' efforts to educate our patients, both children and adults, about the dangers of these products and encourage them to lead healthy lifestyles."
"We used to occasionally ask patients if they smoked, or we might have asked if we smelled smoke on the patient," she said. "Now it's just a part of our practice. We ask every patient, and it goes on the chart."

Office champions in the pilot project can be physicians, but they more likely will be practice administrators, nurses, physician assistants or other staff members.

"Having an opportunity to have your team involved makes a difference," Carter Saccocio said. "It's not just the physician. When your whole team buys in to the system, you're more likely to be successful."

The deadline for applications is Aug. 16. Additional information and applications are available online. Members with questions may contact AAFP tobacco control manager and project director Pamela Rodriguez by e-mail or by calling (800) 274-2237, Ext. 3135.

Practices chosen to participate will be announced in September, with implementation and evaluation scheduled to take place from October through May 2011. Practices that complete the program will be reimbursed for administrative costs associated with the project.

Participating practices also will receive a recognition kit that includes
  • a certificate that states, "This practice is recognized by the American Academy of Family Physicians for excellence in tobacco cessation assistance;"
  • a news release to send to local newspapers;
  • a certificate for the office champion indicating he or she has completed tobacco cessation training by the Academy;
  • an article for patient newsletters;
  • electronic "Tobacco Treatment Excellence" logos to use on letterhead, business cards, advertisements, etc.;
  • tips on having a recognition ceremony for staff;
  • tips on publicizing the practice's office champion status; and
  • posters for the office.
Additionally, practices that complete the project will receive recognition
  • in an advertisement in American Family Physician,
  • in materials distributed at the 2010 AAFP Scientific Assembly and the 2010 National Conference of Family Medicine Residents and Medical Students, and
  • on the AAFP website.
The project is supported by a $400,000 grant from Pfizer Inc.

Share this on AAFP Connection

Health of the Public

Study: PPI Does Not Routinely Improve Asthma Control

Recalled Oral Contraceptives Pose Pregnancy Risk

CDC to Fund 2D Vaccine Barcoding Pilot

2012 Immunization Schedules Reflect Multiple Changes

Study: Cognitive Decline Detected in Middle-aged Adults

CDC Toolkit Can Help Clinicians Fight Norovirus Infection

Patient-Centered Care Linked to Lower Mortality

Study: Inappropriate Cancer Screenings Continue

Novartis Manufacturing Plant Closes After Drug Mix-ups

FDA Announces Classwide REMS for TIRF Medications

New Infants' Acetaminophen Products Hit Store Shelves

Avoid Environmental Factors Linked to Breast Cancer

Risk for Thrombosis Prompts REMS for Rivaroxaban

Common Drugs Implicated in Most Emergency Hospitalizations

CDC Launches Campaign for Child Medication Safety

HHS Blocks Expanded OTC Access to Plan B

Push Is On to Vaccinate Pregnant, Postpartum Women

FDA Committee Votes to Broaden PCV13 Indication

AAFP Foundation Program Aims to Fight Chronic Disease

NIAAA Alcohol Screening Guide Targets Teens

Walgreens, AAFP Launch Flu Vaccine Pilot in Five States

Helping Patients Quit Smoking Starts With a Question

Trilipix Efficacy in Question, Says FDA

USPSTF Addresses Skin Cancer, Obesity, Cervical Cancer Screening

AAFP Endorses ACP Guideline on ED

ACIP Recommends Expanded HPV, Hepatitis B Vaccination

Bacterial Contamination Spurs Nasal Spray Recall

CDC Renews Call for PCV13 Vaccination

USPSTF Recommends Against PSA Screening

AAFP Supports HHS' Million Hearts Initiative

FDA Phases Out Primatene Mist Inhalers

AHRQ Guides Explain Benefits, Risks of GERD Treatments

Tar Wars Winner Gives Back

Office Champions Project Nets Smoking Cessation Gains

Multiple Lots of Oral Contraceptives Recalled

New Vaccine Review Finds Few Adverse Events

HPV Vaccination Rates Still Lag, Says CDC

Renal Injury Prompts Reclast Label Changes

High-dose Citalopram Linked to Abnormal Heart Rhythms

AHRQ Sleep Apnea Guides Review Diagnosis, Management

Board Chair Spotlights Breadth of Family Medicine Training

USPSTF Softens Stance on Bladder Cancer Screening

HHS Expands Coverage for Women's Preventive Services

Teledermatology Project Aids Underserved Patients

New Chantix Warnings Cite Cardiovascular Risk

Pertussis Outbreaks Lead to CDC Alert on PCR Testing